152 related articles for article (PubMed ID: 27373439)
41. Partial ventilatory support modalities in acute lung injury and acute respiratory distress syndrome-a systematic review.
McMullen SM; Meade M; Rose L; Burns K; Mehta S; Doyle R; Henzler D;
PLoS One; 2012; 7(8):e40190. PubMed ID: 22916094
[TBL] [Abstract][Full Text] [Related]
42. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.
He YQ; Zhou CC; Yu LY; Wang L; Deng JL; Tao YL; Zhang F; Chen WS
Pharmacol Res; 2021 Jan; 163():105224. PubMed ID: 33007416
[TBL] [Abstract][Full Text] [Related]
43. Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up.
Lv HL; Jin DM; Liu M; Liu YM; Wang JF; Geng DF
Pharmacol Res; 2014 Mar; 81():64-73. PubMed ID: 24602799
[TBL] [Abstract][Full Text] [Related]
44. Approaches to conventional mechanical ventilation of the patient with acute respiratory distress syndrome.
Hess DR
Respir Care; 2011 Oct; 56(10):1555-72. PubMed ID: 22008397
[TBL] [Abstract][Full Text] [Related]
45. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS.
Tsangaris I; Tsantes A; Bonovas S; Lignos M; Kopterides P; Gialeraki A; Rapti E; Orfanos S; Dimopoulou I; Travlou A; Armaganidis A
Thromb Res; 2009 Apr; 123(6):832-6. PubMed ID: 18804848
[TBL] [Abstract][Full Text] [Related]
46. The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis.
Wang Y; Zhong M; Wang Z; Song J; Wu W; Zhu D
Crit Care; 2018 Mar; 22(1):60. PubMed ID: 29519254
[TBL] [Abstract][Full Text] [Related]
47. Pharmacotherapy for acute respiratory distress syndrome.
Shafeeq H; Lat I
Pharmacotherapy; 2012 Oct; 32(10):943-57. PubMed ID: 23033233
[TBL] [Abstract][Full Text] [Related]
48. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.
Meduri GU; Bridges L; Shih MC; Marik PE; Siemieniuk RAC; Kocak M
Intensive Care Med; 2016 May; 42(5):829-840. PubMed ID: 26508525
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
Li H; Wang C; Liu C; Li R; Zou M; Cheng G
Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
[TBL] [Abstract][Full Text] [Related]
50. Effect of different types and dosages of statins on plasma lipoprotein(a) levels: A network meta-analysis.
Wang X; Li J; Ju J; Fan Y; Xu H
Pharmacol Res; 2021 Jan; 163():105275. PubMed ID: 33166736
[TBL] [Abstract][Full Text] [Related]
51. The effect of diabetes on the risk and mortality of acute lung injury/acute respiratory distress syndrome: A meta-analysis.
Ji M; Chen M; Hong X; Chen T; Zhang N
Medicine (Baltimore); 2019 Mar; 98(13):e15095. PubMed ID: 30921244
[TBL] [Abstract][Full Text] [Related]
52. Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies.
Verghis RM; McDowell C; Blackwood B; Lee B; McAuley DF; Clarke M
Trials; 2023 Mar; 24(1):183. PubMed ID: 36907882
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological treatments for acute respiratory distress syndrome: systematic review.
Duggal A; Ganapathy A; Ratnapalan M; Adhikari NK
Minerva Anestesiol; 2015 May; 81(5):567-88. PubMed ID: 24937499
[TBL] [Abstract][Full Text] [Related]
54. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
[TBL] [Abstract][Full Text] [Related]
55. Association between inflammatory biomarkers and acute respiratory distress syndrome or acute lung injury risk : A systematic review and meta-analysis.
Liu Z; Liu D; Wang Z; Zou Y; Wang H; Li X; Zheng D; Zhou G
Wien Klin Wochenschr; 2022 Jan; 134(1-2):24-38. PubMed ID: 34860273
[TBL] [Abstract][Full Text] [Related]
56. Acute lung injury: The therapeutic role of Rho kinase inhibitors.
Abedi F; Hayes AW; Reiter R; Karimi G
Pharmacol Res; 2020 May; 155():104736. PubMed ID: 32135249
[TBL] [Abstract][Full Text] [Related]
57. Influence of Clinical Factors and Exclusion Criteria on Mortality in ARDS Observational Studies and Randomized Controlled Trials.
Pais FM; Sinha P; Liu KD; Matthay MA
Respir Care; 2018 Aug; 63(8):1060-1069. PubMed ID: 29991643
[TBL] [Abstract][Full Text] [Related]
58. Impact of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis.
Horita N; Hashimoto S; Miyazawa N; Fujita H; Kojima R; Inoue M; Ueda A; Ishigatsubo YI; Kaneko T
Intern Med; 2015; 54(12):1473-9. PubMed ID: 26267908
[TBL] [Abstract][Full Text] [Related]
59. [Effect of statins on occurrence of infection and infection-related mortality: a meta-analysis].
Wang G; Zhang Y; Xie X; Han D; Wu Y; Li S; Li F; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):988-93. PubMed ID: 25057070
[TBL] [Abstract][Full Text] [Related]
60. Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre-existing diabetes: a meta-analysis.
Gu WJ; Wan YD; Tie HT; Kan QC; Sun TW
PLoS One; 2014; 9(2):e90426. PubMed ID: 24587357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
